Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Standard Biotools (LAB) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to $37.0 million.

  • Standard Biotools' Other Gross PP&E Adjustments fell 4579.96% to $37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year decrease of 4579.96%. This contributed to the annual value of $22.4 million for FY2024, which is 360.31% down from last year.
  • Per Standard Biotools' latest filing, its Other Gross PP&E Adjustments stood at $37.0 million for Q3 2025, which was down 4579.96% from $31.8 million recorded in Q2 2025.
  • Standard Biotools' Other Gross PP&E Adjustments' 5-year high stood at $76.6 million during Q1 2025, with a 5-year trough of -$33.0 million in Q2 2021.
  • For the 5-year period, Standard Biotools' Other Gross PP&E Adjustments averaged around $20.4 million, with its median value being $15.5 million (2022).
  • As far as peak fluctuations go, Standard Biotools' Other Gross PP&E Adjustments crashed by 27314.1% in 2021, and later skyrocketed by 48817.37% in 2024.
  • Quarter analysis of 5 years shows Standard Biotools' Other Gross PP&E Adjustments stood at $5.6 million in 2021, then surged by 174.56% to $15.5 million in 2022, then surged by 49.59% to $23.2 million in 2023, then dropped by 3.6% to $22.4 million in 2024, then soared by 65.23% to $37.0 million in 2025.
  • Its Other Gross PP&E Adjustments was $37.0 million in Q3 2025, compared to $31.8 million in Q2 2025 and $76.6 million in Q1 2025.